General medicines
Product information:
- RELENZA product monograph (PDF - 669 KB)
Health-care Professional Information:
- November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information (PDF - 30.3 KB) on PrRELENZA (zanamivir) Dry Powder for Inhalation
Consumer Information:
- “Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”
Information (PDF - 669 KB)
